NEW YORK (GenomeWeb News) – GE Healthcare today it has settled with Bio-Rad Laboratories over litigation related to GE Healthcare Life Sciences' technology for studying molecular interactions with surface plasmon resonance.
Financial terms of the settlement were not disclosed. In 2010 GE Healthcare sued Bio-Rad in Germany alleging infringement of SPR-related patents.
GE Healthcare said that it and Bio-Rad have withdrawn their claims and GE Healthcare has granted a license to Bio-Rad to a collection of patents, which relate to certain aspects of GE Healthcare's technology and Biacore instrument for SPR-based quantitative studies of molecular interactions.
The non-exclusive license gives Bio-Rad rights to use GE Healthcare's technologies in Bio-Rad's SPR products.